Assyro AI

Orange Book product · Generic (ANDA)

TOREMIFENE CITRATE

TOREMIFENE CITRATE

Generic (ANDA)ANDA 208813TE ABRX RISING

At a glance

Dec 04, 2018

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 04, 2018

    7 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

TOREMIFENE CITRATE

Strength

EQ 60MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 208813

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of TOREMIFENE CITRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.